Clay Siegall, Morphimmune CEO

Up­dat­ed: Ex-Seagen chief Clay Sie­gall emerges as CEO of pri­vate biotech

Clay Sie­gall will be back in the CEO seat, tak­ing the helm of a pri­vate start­up work­ing on tar­get­ed can­cer ther­a­pies.

It’s been al­most a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.